In addition, monophasic SS revealed higher mRNA levels of both the M1 macrophage marker NOS2 and the M2 macrophage marker ARG1, which supports the assumption of stronger immunosuppression in monophasic SS and suggests a poorer response of monophasic SS to chemotherapy as compared with biphasic tumors. Here, ARG1 is linked to synovial sarcoma.